20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Brain Edema in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, W; Lu, L; Wang, M; Wei, X; Yuan, F | 1 |
Alexander, H; Clark, RS; Kochanek, PM; Manole, MD; Poloyac, SM; Shaik, JS; Tudorascu, DL | 1 |
2 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Brain Edema
Article | Year |
---|---|
Roles of elevated 20‑HETE in the breakdown of blood brain barrier and the severity of brain edema in experimental traumatic brain injury.
Topics: Animals; Blood-Brain Barrier; Brain Edema; Brain Injuries, Traumatic; Capillary Permeability; Hydroxyeicosatetraenoic Acids; Male; Matrix Metalloproteinase 9; Occludin; Oxidative Stress; Rats, Sprague-Dawley; Zonula Occludens-1 Protein | 2018 |
20-Hydroxyeicosatetraenoic Acid Inhibition by HET0016 Offers Neuroprotection, Decreases Edema, and Increases Cortical Cerebral Blood Flow in a Pediatric Asphyxial Cardiac Arrest Model in Rats.
Topics: Amidines; Animals; Asphyxia Neonatorum; Body Water; Brain Chemistry; Brain Edema; Cerebral Cortex; Cerebrovascular Circulation; Cytochrome P-450 Enzyme System; Eicosanoids; Heart Arrest; Hydroxyeicosatetraenoic Acids; Male; Neurodegenerative Diseases; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2015 |